Reduction in rotavirus disease due to the infant immunisation programme in England; evidence from national surveillance - 04/06/15
Doi : 10.1016/j.jinf.2015.01.007
Christina Atchison ⁎ 
, Sarah Collins
, Sarah Collins Immunisation, Hepatitis and Blood Safety Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK
∗Corresponding author. Department of Primary Care and Public Health, Room 332, Reynolds Building, Imperial College London, Charing Cross Campus, London W6 8RF, UK. Tel.: +44 0207 5948703.
David Brown
Virus Reference Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK
Mary E. Ramsay, Shamez Ladhani
The PHE Rotavirus Surveillance Network includesa
Rohini Manuel, Dr b, Duncan Clark, Dr b, John Magee, Dr c, Husam Osman, Dr d, Anthony D. Hale, Dr e, Hamid Jalal, Dr f, Mark Farrington, Dr f, Martin L’Estrange, Dr f, Ed Kaczmarski, Dr g, Andrew Turner, Dr g, Emanuela Pelosi, Dr h, Peter Hawtin, Dr h, David Carrington, Dr i, Adam Finn, Dr i
b Public Health Laboratory London, Barts Health NHS Trust, London E1 2ES
c Public Health Laboratory Newcastle, Freeman Hospital, Newcastle NE7 7DN
d Public Health Laboratory Birmingham, Heart of England NHS Foundation Trust, Birmingham B9 5SS
e Public Health Laboratory Leeds, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX
f Public Health Laboratory Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0QW
g Public Health Laboratory Manchester, Manchester Royal Infirmary, Manchester M13 9WZ
h Public Health Laboratory Southampton, Southampton General Hospital, Southampton SO16 6YD
i Public Health Laboratory Bristol, Bristol BS2 8EL
Keywords : Rotavirus, Gastroenteritis, Diarrhoea, Vaccination, Immunisation
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 1
P. 128-131 - juillet 2015 Retour au numéro
Article précédent
- Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates
- Sophie Jones, Lynn Grignard, Issa Nebie, Jaffu Chilongola, Daniel Dodoo, Robert Sauerwein, Michael Theisen, Will Roeffen, Shrawan Kumar Singh, Rajesh Kumar Singh, Sanjay Singh, Eric Kyei-Baafour, Kevin Tetteh, Chris Drakeley, Teun Bousema
- Polyvalent immunoglobulins in neonates after perinatal exposure to measles : Benefits and long-term tolerance of immunoglobulins
- Caroline Charlier, Sophie Hourrier, Marianne Leruez-Ville, Jean Ralph Zahar, Daniel Floret, Laurent J. Salomon, Julie Toubiana, Marc Lecuit, Alexandre Lapillonne, Olivier Lortholary, Elsa Kermorvant-Duchemin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?